Therapeutic drug monitoring of isoniazid, rifampin, and pyrazinamide in HIV-infected patients with tuberculosis

被引：0
|
作者：
Baniasadi, Shadi [1 ]
Fahimi, Fanak [2 ]
Tabarsi, Payam [2 ]
Nadji, Seyed Alireza [1 ]
Khabiri, Shadi [2 ]
Shahsavari, Nahid [3 ]
Kobarfard, Farzad [3 ]
机构：
[1] Natonal Res Inst TB & Lung Dis, Virol Res Ctr, Tehran, Iran
[2] Natonal Res Inst TB & Lung Dis, Chron Resp Dis Res Ctr, Tehran, Iran
[3] Shahid Beheshti Univ Med Sci, Med Chem Dept, Sch Pharm, Tehran, Iran
来源：
EUROPEAN RESPIRATORY JOURNAL | 2012年 / 40卷
关键词：
Pharmacology; Infections; Treatments;
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
2959
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Feasibility and Efficacy of Isoniazid Prophylaxis for Latent Tuberculosis in HIV-Infected Clients Patients in Thailand
    Khongphatthanayothin, Mana
    Avihingsanon, Anchalee
    Teeratakulpisarn, Nipat
    Phanuphak, Nittaya
    Buajoom, Raksakul
    Suwanmala, Pilin
    Phanuphak, Praphan
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2012, 28 (03) : 270 - 275
  • [42] Rifampin and recurrence of tuberculosis among patients infected with HIV
    Lambert, ML
    Hasker, E
    Van Deun, A
    Roberfroid, D
    Van der Stuyft, P
    CLINICAL INFECTIOUS DISEASES, 2003, 37 (12) : 1719 - 1720
  • [43] Therapeutic Drug Monitoring in the Management of HIV-Infected Patients (vol 15, pg 1925, 2008)
    Ivanovic, Jelena
    Nicastri, Emanuele
    Ascenzi, Paolo
    Bellagamba, Rita
    De Marinis, Elisabetta
    Notari, Stefania
    Pucillo, Leopoldo Paolo
    Tozzi, Valerio
    Ippolito, Giuseppe
    Narciso, Pasquale
    CURRENT MEDICINAL CHEMISTRY, 2008, 15 (30) : 3280 - 3280
  • [44] Despite limitations, therapeutic drug monitoring may be of value in antiretroviral treatment in HIV-infected patients
    Drugs & Therapy Perspectives, 2005, 21 (7) : 24 - 26
  • [45] Treatment of tuberculosis in HIV-infected patients:: safety and antiretroviral efficacy of the concomitant use of ritonavir and rifampin
    Moreno, S
    Podzamczer, D
    Blázquez, R
    Iribarren, JA
    Ferrer, E
    Reparaz, J
    Peña, JM
    Cabrero, E
    Usán, L
    AIDS, 2001, 15 (09) : 1185 - 1187
  • [46] Weekly rifapentine/isoniazid or daily rifampin/pyrazinamide for latent tuberculosis in household contacts
    Schechter, M
    Zajdenverg, R
    Falco, G
    Barnes, GL
    Faulhaber, JC
    Coberly, JS
    Moore, RD
    Chaisson, RE
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2006, 173 (08) : 922 - 926
  • [47] Tuberculosis in HIV-infected patients in Honduras
    Andersson, K
    Aronsson, M
    Alvarado-Galvez, C
    Pineda-Garcia, L
    Hoffner, SE
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 1999, 3 (07) : 640 - 640
  • [48] HIV-1 Coinfection Does Not Reduce Exposure to Rifampin, Isoniazid, and Pyrazinamide in South African Tuberculosis Outpatients
    Rockwood, Neesha
    Meintjes, Graeme
    Chirehwa, Maxwell
    Wiesner, Lubbe
    McIlleron, Helen
    Wilkinson, Robert J.
    Denti, Paolo
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (10) : 6050 - 6059
  • [49] Prevention of tuberculosis in HIV-infected patients
    Nahid, P
    Daley, CL
    CURRENT OPINION IN INFECTIOUS DISEASES, 2006, 19 (02) : 189 - 193
  • [50] ENDOBRONCHIAL TUBERCULOSIS IN HIV-INFECTED PATIENTS
    CALPE, JL
    CHINER, E
    LARRAMENDI, CH
    AIDS, 1995, 9 (10) : 1159 - 1164
12345